Logo image of TRDA

ENTRADA THERAPEUTICS INC (TRDA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:TRDA - US29384C1080 - Common Stock

10.875 USD
-0.11 (-0.96%)
Last: 12/22/2025, 10:30:50 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
TRDA revenue by date.TRDA revenue by date.
129.013M210.782M
63.38%
33.256M
-84.22%
34.307M
3.16%
56.559M
64.86%

-100.00%
25.5M51M
100.00%
EBITDA
YoY % growth
TRDA ebitda by date.TRDA ebitda by date.
-95.35M
-90.66%
-321K
99.66%
50.784M
15,920.56%
-149.649M
-394.68%
-215.133M
-43.76%
-283.865M
-31.95%
N/AN/AN/AN/A
EBIT
YoY % growth
TRDA ebit by date.TRDA ebit by date.
-97.25M
-90.20%
-3.162M
96.75%
47.011M
1,586.75%
-165.031M
-451.05%
-211.831M
-28.36%
-253.109M
-19.49%
-260.1M
-2.76%
-285.6M
-9.80%
-293.25M
-2.68%
-270.3M
7.83%
Operating Margin
TRDA operating margin by date.TRDA operating margin by date.
N/A-2.45%22.30%-496.24%-617.46%-447.51%N/AN/A-1,150.00%-530.00%
EPS
YoY % growth
TRDA eps by date.TRDA eps by date.
-3.02
63.24%
-0.26
91.39%
1.91
834.62%
-3.68
-292.52%
-4.21
-14.62%
-4.14
1.74%
6.18
249.26%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.00
-3,425.20%
-1.02
-142.71%
-1.12
-7.92%
-1.11
-4.45%
-1.24
-24.74%
Revenue
Q2Q % growth
14.164M
-62.13%
9.193M
-55.28%
1.72M
-11.79%
2.927M
81.35%
8.196M
-42.13%
EBITDA
Q2Q % growth
-34.92M
-1,562.84%
-27.218M
-30.58%
-60.233M
-34.24%
N/AN/A
EBIT
Q2Q % growth
-47.045M
-701.45%
-45.515M
-108.88%
-56.597M
-20.81%
-56.297M
-19.65%
-71.773M
-52.56%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.06
-202.86%
-0.96-0.10-10.55%
Q2 2025
Q2Q % growth
-1.04
-167.10%
-0.86-0.18-20.31%
Q1 2025
Q2Q % growth
-0.42
-161.76%
-0.800.3847.81%
Q4 2024
Q2Q % growth
0.03
110.34%
-0.680.71104.39%
Q3 2024
Q2Q % growth
-0.35
-134.31%
-0.740.3952.87%
Q2 2024
Q2Q % growth
1.55
298.72%
0.151.40948.01%
Q1 2024
Q2Q % growth
0.68
423.81%
-0.611.29212.23%
Q4 2023
Q2Q % growth
-0.29
63.29%
-0.17-0.12-69.23%
Q3 2023
Q2Q % growth
1.02
227.50%
-0.751.77235.92%
Q2 2023
Q2Q % growth
-0.78
-5.41%
-0.70-0.08-10.83%
Q1 2023
Q2Q % growth
-0.21
69.57%
0.99-1.20-121.28%
Q4 2022
Q2Q % growth
-0.79
11.24%
-0.840.056.31%
Q3 2022
Q2Q % growth
-0.80
91.82%
-0.78-0.02-3.20%
Q2 2022
Q2Q % growth
-0.74 -0.740.00-0.21%
Q1 2022
Q2Q % growth
-0.69 -0.67-0.02-3.28%
Q4 2021
Q2Q % growth
-0.89 -1.310.4232.04%
Q3 2021
Q2Q % growth
-9.78 -0.89-8.89-1,002.10%
TRDA Yearly EPS VS EstimatesTRDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.614M
-91.75%
13.976M-12.362M-88.45%
Q2 2025
Q2Q % growth
1.95M
-97.94%
9.844M-7.894M-80.19%
Q1 2025
Q2Q % growth
20.558M
-65.23%
10.374M10.184M98.17%
Q4 2024
Q2Q % growth
37.398M
-10.63%
13.383M24.015M179.44%
Q3 2024
Q2Q % growth
19.57M
-55.25%
12.567M7.003M55.73%
Q2 2024
Q2Q % growth
94.694M
421.16%
46.997M47.697M101.49%
Q1 2024
Q2Q % growth
59.12M
134.05%
15.276M43.844M287.01%
Q4 2023
Q2Q % growth
41.848M 24.169M17.679M73.15%
Q3 2023
Q2Q % growth
43.735M 9.789M33.946M346.78%
Q2 2023
Q2Q % growth
18.17M 9.972M8.198M82.21%
Q1 2023
Q2Q % growth
25.26M 121.38M-96.12M-79.19%
TRDA Yearly Revenue VS EstimatesTRDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2030 2031 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS5.78% 8.6% -2.12% -2.12%
Revenue47.36% 130.08% -16.93% -4.27%